Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells
Year: 2016
Type: article
Source: Cancer Research
Institutions: The University of Queensland, QIMR Berghofer Medical Research Institute, The University of Melbourne, Peter MacCallum Cancer Centre, Université Paris-Sud, Inserm, Université Paris-Saclay, Institut Gustave Roussy, Centre de recherche en Epidémiologie et Santé des Populations, Fondation Gustave Roussy, University of Helsinki, Helsinki University Hospital, Tampere University Hospital, Université Libre de Bruxelles, Institut Jules Bordet
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2224619536
